Search research articles
Contact Us
Filters
Showing results (101-110 of 307) with videos related to
Page
of 31
Sort By:
Urologic Oncology
|
December 4, 2019
Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling
Kevin Ginsburg, Adam I Cole, Michael E Silverman, et al.
European Urology
|
May 18, 2023
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review
Oskar Bergengren, Kelly R Pekala, Konstantina Matsoukas, et al.
JCO Precision Oncology
|
June 6, 2025
Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma
Steven M Monda, Srinivas Nallandhighal, Ulka Vaishampayan, et al.
Oncotarget
|
March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Younghun Jung, Ann M Decker, Jingcheng Wang, et al.
European Urology Oncology
|
May 18, 2019
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients
Sarah P Psutka, Daniel A Barocas, James W F Catto, et al.
The Journal of Urology
|
July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy
Todd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
Cancers
|
December 9, 2023
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
Mark Farha, Srinivas Nallandhighal, Randy Vince, et al.
BJU International
|
September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Urology Practice
|
May 5, 2023
Delayed Urological Cancer Care during the COVID-19 Pandemic: Urologists' Experience
Daniela Wittmann, Anna Faris, James E Montie, et al.
Urologic Oncology
|
December 3, 2014
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Opal Lin-Tsai, Kelly L Stratton, et al.
Page
of 31
Search research articles
Search
Showing results (101-110 of 307) with videos related to
Sort By:
Page
of 31
Urologic Oncology
|
December 4, 2019
Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling
Kevin Ginsburg, Adam I Cole, Michael E Silverman, et al.
European Urology
|
May 18, 2023
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review
Oskar Bergengren, Kelly R Pekala, Konstantina Matsoukas, et al.
JCO Precision Oncology
|
June 6, 2025
Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma
Steven M Monda, Srinivas Nallandhighal, Ulka Vaishampayan, et al.
Oncotarget
|
March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Younghun Jung, Ann M Decker, Jingcheng Wang, et al.
European Urology Oncology
|
May 18, 2019
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients
Sarah P Psutka, Daniel A Barocas, James W F Catto, et al.
The Journal of Urology
|
July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy
Todd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
Cancers
|
December 9, 2023
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype
Mark Farha, Srinivas Nallandhighal, Randy Vince, et al.
BJU International
|
September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Urology Practice
|
May 5, 2023
Delayed Urological Cancer Care during the COVID-19 Pandemic: Urologists' Experience
Daniela Wittmann, Anna Faris, James E Montie, et al.
Urologic Oncology
|
December 3, 2014
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Opal Lin-Tsai, Kelly L Stratton, et al.
Page
of 31